Zebra Capital Management’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,293
Closed -$238K 173
2021
Q3
$238K Sell
4,293
-980
-19% -$54.4K 0.29% 127
2021
Q2
$286K Sell
5,273
-206
-4% -$11.3K 0.34% 108
2021
Q1
$307K Sell
5,479
-1,826
-25% -$91.1K 0.34% 107
2020
Q4
$318K Sell
7,305
-340
-4% -$13.4K 0.4% 115
2020
Q3
$298K Buy
7,645
+2,662
+53% +$117K 0.46% 109
2020
Q2
$215K Buy
+4,983
New +$189K 0.31% 143
2020
Q1
Sell
-5,453
Closed -$226K 277
2019
Q4
$226K Buy
+5,453
New +$230K 0.2% 213

Other funds holding SRDX

Zebra Capital Management's SRDX Position: Q4 2021 in Review

Zebra Capital Management sold out of Surmodics (SRDX) in Q4 2021, closing a stake of 4,293 shares — an estimated $238K sold.

Zebra Capital Management first reported a position in SRDX in Q4 2019 and held it in 7 quarters. The position peaked at $318K in Q4 2020. 148 funds tracked by Wall St. Rank hold SRDX as of Q4 2021.

  • Zebra Capital Management reported no remaining Surmodics position as of Q4 2021 after selling out during the quarter.
  • Zebra Capital Management sold 4,293 Surmodics shares in Q4 2021, an estimated $238K.
  • Zebra Capital Management first reported a position in Surmodics in Q4 2019 and held it in 7 quarters.
  • Zebra Capital Management's Surmodics position peaked at $318K in Q4 2020.
  • 148 funds tracked by Wall St. Rank held Surmodics as of Q4 2021.

Based on Zebra Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.